Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Journal of Hepatocellular Carcinoma
|
February 27, 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1<sup>+</sup> Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Yuxin Liang, Deyuan Zhong, Qinyan Yang, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 6, 2025
Topological Distribution of KCNH2 Variants and Genotype-Phenotype Relationship in Patients With Long QT Syndrome
Hongyu Liu, Zhenhong Jiang, Yang Shen, et al.
Frontiers in Immunology
|
December 12, 2025
Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis
Deyuan Zhong, Yuxin Liang, YaHui Chen, et al.
Frontiers in Immunology
|
September 12, 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
Yuxin Liang, Ming Wang, Deyuan Zhong, et al.
BMC Cancer
|
March 7, 2025
Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
Yuxin Liang, Deyuan Zhong, Jin Shang, et al.
BMC Cancer
|
March 20, 2025
Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 8, 2026
TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Translational Medicine
|
June 19, 2026
S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H<sub>2</sub>S-linked vascular and immune reprogramming
Yuxin Liang, Deyuan Zhong, Hongtao Yan, et al.
European Journal of Radiology
|
February 18, 2026
Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 2, 2022
Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against <i>Bordetella pertussis</i> in a Mouse Model
Wenwen Jiang, Xiaoyu Wang, Yuhao Su, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Journal of Hepatocellular Carcinoma
|
February 27, 2024
Single-Cell RNA Sequencing Revealed That the Enrichment of TPI1<sup>+</sup> Malignant Hepatocytes Was Linked to HCC Metastasis and Immunosuppressive Microenvironment
Yuxin Liang, Deyuan Zhong, Qinyan Yang, et al.
Pacing and Clinical Electrophysiology : PACE
|
February 6, 2025
Topological Distribution of KCNH2 Variants and Genotype-Phenotype Relationship in Patients With Long QT Syndrome
Hongyu Liu, Zhenhong Jiang, Yang Shen, et al.
Frontiers in Immunology
|
December 12, 2025
Preoperative TACE with PD-1 inhibitors and TKIs in beyond "up-to-seven" hepatocellular carcinoma: a propensity score matched analysis
Deyuan Zhong, Yuxin Liang, YaHui Chen, et al.
Frontiers in Immunology
|
September 12, 2025
Efficacy and safety of postoperative adjuvant HAIC combining lenvatinib with or without PD-1 inhibitors in solitary large HCC: A multicenter retrospective study
Yuxin Liang, Ming Wang, Deyuan Zhong, et al.
BMC Cancer
|
March 7, 2025
Efficacy and safety of postoperative adjuvant HAIC with FOLFOX combining PD-1 inhibitors in HCC patients with microvascular invasion: a propensity score matching analysis
Yuxin Liang, Deyuan Zhong, Jin Shang, et al.
BMC Cancer
|
March 20, 2025
Construction and validation of a novel liver function-tumor burden-inflammation-nutrition (LTIN) score for HCC patients underwent hepatectomy
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 8, 2026
TACE plus lenvatinib and envafolimab for conversion therapy in unresectable HCC: a prospective pilot study
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Journal of Translational Medicine
|
June 19, 2026
S-propargyl-cysteine remodels the HCC microenvironment and potentiates anti-PD-1 therapy through CSE/H<sub>2</sub>S-linked vascular and immune reprogramming
Yuxin Liang, Deyuan Zhong, Hongtao Yan, et al.
European Journal of Radiology
|
February 18, 2026
Development and validation of a nomogram to predict surgical resection after conversion therapy in unresectable hepatocellular carcinoma
Yuhao Su, Yuxin Liang, Deyuan Zhong, et al.
Frontiers in Immunology
|
May 2, 2022
Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against <i>Bordetella pertussis</i> in a Mouse Model
Wenwen Jiang, Xiaoyu Wang, Yuhao Su, et al.
Page
of 5